Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Paragon 28, Inc.

FNANYSE
Healthcare
Medical - Devices
$13.09
$0.00(0.00%)
U.S. Market opens in 16h 9m

Paragon 28, Inc. (FNA) Stock Overview

Explore Paragon 28, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio-46.49
EPS (TTM)$-0.66
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$1.36

FNA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Paragon 28, Inc. (FNA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $1.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -46.49 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
0.15%
6-Month Change
30.77%
Year-to-Date (YTD) Change
22.11%
1-Year Change
70.89%
3-Year Change
-16.57%
5-Year Change
-30.04%
All-Time (Max) Change
-30.04%

Contact Information

730 399 3400
14445 Grasslands Drive, Englewood, CO, 80112

Company Facts

5,250 Employees
IPO DateOct 15, 2021
CountryUS

Frequently Asked Questions